-
Vaccination is the only long-term solution to COVID-19 crisis in India: Fauci
expresspharma
May 11, 2021
He called for scaling up manufacturing of coronavirus vaccines both domestically and globally to fight the deadly pandemic.
-
COVID strain identified in India is ‘variant of concern’: WHO
expresspharma
May 11, 2021
There is some available information to suggest increased transmissibility of B-1617, said Dr Maria Van Kerkhove, COVID-19 Technical Lead at the World Health Organisation (WHO).
-
India will study claim of Sputnik Light: Dr VK Paul
expresspharma
May 10, 2021
India will examine the claim that a single dose of Russian vaccine ‘Sputnik Light’ can provide protection from the novel coronavirus infection, said NITI Aayog member V K Paul.
-
Beyond the pandemic: Building collaborative media engagement for clinical research
expresspharma
May 10, 2021
During the last 12 months, conversations in India about clinical trials emerged from the closed doors of sites, sponsors and CROs into the homes of people. Suddenly clinical trials had become a household term.
-
A masterstroke needed from the PM to accelerate Universal COVID-19 vaccination – A letter to the PM
expresspharma
May 10, 2021
Chandru Chawla, a pharma industry veteran, writes an open letter to the Prime Minister of India on the immediate steps and radical measures needed to streamline and improve India's COVID-19 vaccination program.
-
Cipla signs licensing deal with Lilly to manufacture and commercialise baricitinib in India
expresspharma
May 10, 2021
Baricitinib was issued a restricted emergency use approval by CDSCO to treat COVID-19.
-
Lam Research Commits $1 Million to Battle Against COVID-19 in India
prnasia
May 08, 2021
Lam Research announced it will donate $1 million (~7.5 cr INR) for COVID-19 relief and recovery efforts in India. The funds will support both local efforts in Bangalore and the Direct Relief organization's efforts to provide oxygen concentrators and ...
-
Glenmark launches Ryaltris-AZ in India
expresspharma
May 07, 2021
Glenmark Pharmaceuticals announced the launch of Ryaltris-AZ Nasal Spray, a novel fixed-dose combination of Mometasone furoate 50 mcg + Azelastine 140 mcg, for the treatment of moderate to severe allergic rhinitis, in India.
-
Centre has so far provided over 16.54 crore vaccine doses to states/UTs for free
expresspharma
May 07, 2021
The Government of India (GOI) has so far provided nearly 16.54 crore vaccine doses (16,54,93,410) to states/UTs free of cost. Of this, the total consumption including wastages is 15,79,21,537 doses (as per data available at 8 am 3rd).
-
Serum Institute of India to make £240 mn investments in UK
expresspharma
May 07, 2021
Serum’s investment will support clinical trials, research and development and possibly manufacturing of vaccines.